Form 4 for QDEL QuidelOrtho Corp
Accepted 2024-04-01 00:00:00 ET · period of report 2024-03-28 · accession 0000950170-24-039668 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-01 | 2024-03-28 | QDEL | Iskra Michael S. | EVP, CCO, Interim CEO | A - Grant | $0.00 | +4,925 | 16.1K | +44% | $0 |
| D | 2024-04-01 | 2024-03-28 | QDEL | Iskra Michael S. | EVP, CCO, Interim CEO | F - Tax | $47.94 | -1,773 | 14.3K | -11% | -$85.0K |
| D | 2024-04-01 | 2024-03-28 | QDEL | Iskra Michael S. | EVP, CCO, Interim CEO | M - OptEx | $0.00 | -4,925 | 9,850 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-28 | A | A | 4,925 | $0.00 | 16,123 | D | — | — | (F1) Reflects release of restricted stock units that were previously reported on a Form 4. (F2) The amount of shares beneficially owned following this transaction includes an additional 291 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-03-28 | F | D | 1,773 | $47.94 | 14,350 | D | — | — | (F3) Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2024-03-28 | M | D | 4,925 | $0.00 | 9,850 | D | — · — to — | 4,925 Common Stock | (F4) Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. (F5) 4,925 shares vested on March 28, 2024; the remaining 9,850 shares will vest in equal installments on March 28, 2025 and March 28, 2026. |